THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: WEEK 12 INTERIM ANALYSES FROM THE PHASE 2 GALAXI 1 STUDY

William Sandborn  1     Daphne Chan  2     Jewel Johanns  2     Grace Lang  2     Omoniyi J. Adedokun  2     Anita Afzali  3     Jane Andrews     Geert R. D'Haens     Silvio Danese     Tadakazu Hisamatsu     Remo Panaccione     Julian PanĂ©s     Walter Reinisch     David T. Rubin     Bruce E. Sands     Brian G. Feagan    
1 University of California San Diego,La Jolla,United States
2 Janssen Research & Development, LLC,Spring House,United States
3 The O

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing